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ABSTRACT 
The study aimed at evaluating liver antioxidant status in streptozotocin (STZ)-induced diabetic male Wistar rats following 
treatment with aqueous Taraxacum officinale leaf extract. The rats were divided into six groups of 6 rats each: Normal control, 
Diabetic control, Non-diabetic rats + 100 mg/kgbw extract, Non-diabetic rats + 200 mg/kgbw extract, Diabetic rats + 100 
mg/kgbw extract and Diabetic rats + 200 mg/kg-bw extract. After the treatment period, the animals were sacrificed and the liver 
was collected, homogenized for biochemical analyses.   Biochemical assays such as the levels of nitrite, lipid peroxidation product 
(LPO), reduced glutathione (GSH) and activities of antioxidant enzymes (superoxide dismutase, SOD and glutathione 
peroxidase, GPx) as well as Ferric Reducing Antioxidant Power (FRAP) were determined using established techniques. Lipid 
peroxidation and nitrite level decreased significantly (p < 0.05) in diabetic rats treated with 100 mg/kgbw and 200 mg/kgbw 
Taraxacum officinale extracts as compared to the untreated diabetic control. There was no significant difference in FRAP value 
in diabetic groups treated with 100mg/kgbw and 200mg/kgbw when compared with the diabetic control. Reduced GSH 
concentration as well as SOD activity increased significantly in diabetic groups treated with 100 mg/kgbw and 200 mg/kgbw 
Taraxacum officinale extracts as compared to the untreated diabetic control while GPx activity decreased significantly in the 
treated diabetic rats. The results indicate that Taraxacum officinale leaf extract could enhance liver anitioxidant status, hence, 
suggest its usefulness in ameliorating diabetic-induced liver injury. 
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INTRODUCTION 
 
Diabetes mellitus has been classified as a metabolic disease 
caused  by excess blood sugar known as hyperglycemia. It is 
a disease condition resulting from unavailability or inability of 
insulin to mediate glucose uptake in the cells as a result of 
either impairment in insulin secretion, insulin action, or both 
(ADA, 2014). Diabetes occurs as type I, where the pancreas 
produces little insulin or no insulin at all leading to 
accumulation of glucose in the blood and type II, a condition 
whereby cells of the organs are unable to recognize the 
presence of insulin in the blood (Schaalan et al., 2009). It has 
been reported that the generation of reactive oxygen species 
(ROS) increases in both type I and type II diabetes and that 
early stage of diabetes is closely connected with oxidative 
stress (Johansen et al., 2005). Oxidative stress in diabetes 
mellitus might occur due to auto-oxidation of glucose, 
imbalance in redox reactions, reduction in GSH and vitamin E 
levels as well as decreased activities of antioxidant enzymes 
(Haskins et al., 2003). Gluco-oxidation due to formation and 
accumulation of advanced glycation end-products (AGE) 
plays a major role in diabetic complications and in the 
mechanisms connecting uncontrolled hyperglycaemia with 
tissue damage in diabetic hepatopathy (Singh et al., 2014). 
Other mechanisms of hyperglycemia-induced diabetic 
complications are through influx of glucose via the polyol 
pathway (Yan, 2018), protein kinase C (PKC) activation (Das 
Evcimen and King, 2007), increased-flux through the 
hexosamine pathway (Wanget al., 2014) and NADPH-oxidase 
pathway (Giacco and Brownlee, 2010).  
 Antioxidants are molecules that are capable of donating one 
or more electrons to unstable free radical(s) and neutralize it, 
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thereby reducing its damaging effect to cells or tissues (Kumar 
et al., 2009). Antioxidants interact with free radicals to stop 
the chain reactions that lead to damages in biological 
macromolecules such as DNA, lipids and proteins. 
Antioxidants are characterized into two; endogenous and 
exogenous antioxidants. Antioxidants produced within the 
organism are referred to as the endogenous and are referred to 
as enzymatic antioxidants such as glutathione peroxidase, 
catalase, glutathione reductase and superoxide dismutase.  
Non-enzymatic antioxidants are reduced glutathione (GSH), 
melatonin, uric acid, coenzyme Q (Birben et al., 2012). 
Exogenous antioxidants are said to be supplied from the diet, 
e.g. β-carotenoids, vitamin E, flavonoids, vitamin C, minerals 
like selenium, iodine, manganese etc (Biehlesr and Bohn, 
2010; Carlsen, 2010). Different foods and supplements rich in 
naturally-occurring antioxidants, such as vitamins and 
phytochemicals such as polyphenols, carotene and flavonoids 
are known antioxidants that can protect the body against 
oxidative damages and enhance antioxidant status of an 
individual (André, 2010; Omar et al., 2011).   
 Herbal medicine has formed the basis of scientific research 
to develop indigenous, inexpensive botanicals with readily 
available biologically active medicinal compounds with little 
or no side effect (Boadu and Asase, 2017). Taraxacum 
officinale, known as dandelion, is a medicinal plant that is 
known to grow wildly in nature in Asia, America, Europe and 
Africa (Molina‐Montenegro, 2013). In the South-Western part 
of Nigeria, it is called ‘efo-yanrin’ and is mostly collected 
from the wild and only cultivated to a limited extent for home 
use and for local markets. In the South-South region of 
Nigeria, the Ijaws (Bayelsa State) of the Niger Delta called it 
‘Edule Imimi’ and the leaves are traditionally used as remedy 
against several ailments such as liver dysfunction, anti-
inflammatory conditions and diabetes mellitus (Sofowora, 
1982; Idu and Ndukwu, 2006).  Taraxacum officinale also 
functions as immunomodulator, insulin stimulant, anti-
carcinogenic digestive stimulant, anti-carcinogenic, prebiotic, 
anti-inflammation, antineoplastic, demulcent, and 
hypoglycaemic (Koh et al., 2010; Ahmed et al., 2013). This 
study investigated the  effect of Taraxacum officinale aqueous 
leaf extract on liver antioxidant status in streptozotocin-
induced diabetic  male Wistar rats. 
 
MATERIALS AND METHODS 
 
Preparation of plant material: Fresh leaves of Taraxacum 
officinale were collected within the months of March-April, 
2019 from a local farm in Ede, Osun State, Nigeria. They were 
identified and authenticated by a Botanist in Biology 
programme of the Department of Basic Science, Adeleke 
University. The fresh leaves of Taraxacum officinale were 
chopped and washed with distilled water to remove extraneous 
materials. They were then dried for 7 days under room 
temperature in a well-ventilated laboratory and occasionally 
turned to avoid fungal growth while drying. The leaves were 
blended into powder. Then, 250g of the powdered leaves 
sample was soaked in 2500ml of distilled water. The content 
was thoroughly stirred and allowed to stand for 24 hours. The 
mixture was then filtered using a clean cotton material and 
refiltered with 0.1mm pores Whatsman filter paper. The 
filtrate was freeze-dried and the extract collected was kept at 
4oC until further use.  
 
Phytochemical Screening 
Cardiac Glycosides: Little quantity of dry powder sample of 
Taraxacum officinale leaf was treated with10ml of ferric 
chloride reagent, containing mixture of ferric chloride solution 
in 1:2v/v glacial acetic acid, 1ml concentrated H2SO4 was 
added to the solution. A blue-green color appearance indicated 
the presence of cardiac glycoside (Ajaiyeoba, 2002). 
Tannin: The aqueous extract of crude dry powder of 
Taraxacum officinale leaf was treated with ethanolic ferric 
chloride solution. A greenish-blue colour indicated the 
presence of tannin (Segelman et al., 1969). 
Steroid: The presence of steroid was confirmed in the crude 
dry powder of Taraxacum officinale leaf after treating the 
chloroform solution of powdered sample with acetic 
anhydride and few drops of concentrated H2SO4. A dark blue 
green color indicated the presence of steroids (Vaghasiyaet al., 
2011). 
Alkaloid: A little quantity of the dried sample powder was 
mixed with methanol. The mixture was filtered and the 
filterate was placed in a boiling water bath  to evaporate. The 
residue mixed  in 2N HCL  was filtered and  divided into three 
parts.  The first part was treated with 1ml of Mayer’s reagent, 
second part was  with 1ml of Dragon’s reagent and the third 
part  with 1ml of Wagner’s reagent. The presence of creamy, 
orange or brown precipitates respectively showed the presence 
of alkaloid (Saleh-Surmghi et al., 1992).  
Saponin: Frotting test was used to determine the presence of 
saponin. The crude dry powder sample of Taraxacum 
officinale was dissolved in enough amount of distilled water 
and shaken vigorously. It was allowed to stand for 10 min to 
observe the frost formation to indicate the presence of saponin. 
Estimation of Total Phenolic Content: The total phenolic 
content in the extract was determined using spectrophotometer 
as described by Singleton et al., (1999). The standard tannic 
acid was prepared by dissolving 10µg of tannic acid in 1ml of 
distilled water to obtain the stock solution. The stock standard 
was further serially diluted by pipetting 0µl, 200µl, 400µl, 
600µl, 800µl and 1000µl and made up to 1ml with distilled 
water. Folin-Ciocalteu’s phenol reagent prepared in 1:10 (v/v) 
ratio with distilled water was added by pipetting 1.5ml of the 
reagent to 200µl from the serial diluted standard and the 
samples. 1.5ml of 7.5% Sodium carbonate was then added 
across the test tubes and allowed to stand for 1hr 30min at 
room temperature. The blank was prepared according to the 
steps above with distilled water in place of the sample. The 
absorbance was read at 725nm against the blank and the 
standard calibration prepared by plotting the graph of 
absorbance against the concentration of tannic acid and the 
concentration of phenolic compound was obtained from the 
equation and expressed as µg/mlTAE; Where TAE = Tannic 
acid equivalent. 
Estimation of Total Flavonoid Content: The total flavonoid 
content in the extract was determined using the method of 
Shen et al., (2009) with rutin as the standard. The standard 
solution was prepared by dissolving 1mg of rutin in 1ml of 
distilled water to form the stock solution. This was serially 
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diluted into 0µl, 200µl, 400µl, 600µl, 800µl and 1000µl and 
made up to 1ml with distilled water. 200µl of the serially 
diluted standard and samples were pipette respectively into 
clean test tubes and added with 300µl freshly prepared 5% 
NaNO2, followed by 300µl of 10% AlCl3 and then 2ml of 4% 
NaOH. The reaction mixtures were then incubated at room 
temperature for 10min and the absorbance read in 
spectrophotometerat 500nm against the blank. The standard 
calibration graph was plotted as absorbance against the rutin 
standard concentration, while the concentration of flavonoids 
in the extract was obtained from the equation and expressed as  
µg/mlRE,  
Where RE = Rutin equivalent. 
 
 
Experimental Animal: Thirty-six (36) adult male Wistar rats 
within the weight of180-250g were purchased from Animal 
House Unit of the Department of Anatomy, Adeleke 
University, Ede, Osun State, Nigeria. The animal study was 
conducted in the Animal House, Department of Biochemistry, 
Adeleke University. Housing was done in wooden cages and 
placed on standard feed with free access to water. . The 
animals were acclimatized under normal conditions of 12h 
light/dark cycle for two weeks before commencement of 
experiment. 
 
Induction of diabetes mellitus: Induction of diabetes 
mellitus was performed according to the method described by 
Hegazy et al., (2013). Streptozotocin concentration (50mg/kg) 
was freshly prepared in 0.1M citrate buffer (pH 4.5) and  
injected intramuscularly into the experimental rats in ratio of 
1ml to 200g body weight.  The rats were allowed to stabilize 
for 3 days, before testing for diabetes. Diabetes was confirmed 
using glucose test strip stained with blood from tail tip 
puncture and analyzed in  Acu-Chek glucometer. The rats with 




Thirty-six (36) male Wistar rats were randomly distributed 
into six groups of 6 rats each.  
Group 1: Normal control rats. 
Group 2: Diabetic control rats. 
Group 3: Non-diabetic rats treated with100mg/kg Taraxacum 
officinale leaf extract. 
Group 4: Non-diabetic rats treated with 200mg/kg Taraxacum 
officinale leaf extract.  
Group 5: Diabetic rats treated with 100mg/kg Taraxacum officinale 
leaf extract. 
Group 6: Diabetic rats treated with 200mg/kg Taraxacum officinale 
leaf extract. 
 
The rats were orally treated for two weeks. At the end of 
experimental period, the rats were fasted overnight, 
anesthetized with diethylether and sacrificed. The liver was 
collected in universal bottles and stored in a refrigerator at a 
temperature of -200C for further use. 
 
Preparation of samples: The samples were prepared 
according to the method described by Amujoyegbe et al., 
(2012). The liver samples were homogenized using 10ml 
phosphate buffer per gramme of the sample. The homogenates 
were centrifuged at a 2500rpm for 20mins. The supernatants 
were collected and kept at – 4oC for biochemical assays. 
Ferric Reducing Antioxidant Power (FRAP) assay: FRAP 
assay was carried out using the method described by Benzie 
and Strain (1996). 2 litres of 0.1M acetate buffer; pH 3.4 was 
prepared using 3.24g of sodium acetate, 32ml of glacial acetic 
acid solution and 500ml of distilled water. The pH was 
adjusted to 3.4 and the volume made up to 2 litres using 
distilled water. 160ml of (tripyridyltriazine) TPTZ solution, 
was prepared using 0.496g of TPTZ in 160ml of 40mM HCL. 
Ferric chloride solution was prepared using 0.512g of ferric 
chloride in 160ml of distilled water. The reagent solutions 
were mixed together to make up the FRAP reagent. 2.0mM 
Standard Ascorbic acid solution was prepared using 0.017g of 
ascorbic acid in 50ml of distilled water as stock solution. Six-
folds serial dilution of 0 µl, 50µl, 100µl, 200µl, 500µl and 
1000µl were prepared and made up to 1ml using distilled 
water. 60µl from each dilution was pipetted into different 
labeled test tubes. Then 1800µl of the FRAP reagent was 
added and shaken to mix properly. The solution was incubated 
at 37oC for 30mins and the absorbance was read at 539nm. 
FRAP in the samples were determined using the standard 
curve and were expressed in micromolar (µM) concentration. 
 
Nitrite assay: The method of Giustarini et al (2004) was used 
to determine nitrite concentration. The Griess reagent used in 
the assay was prepared by dissolving 10ml of phosphoric acid 
in a distilled water making it up to 200ml. 0.2g of N-1-
Naphthylethylenediamine dihydrochloride was dissolved in 
the 200ml solution of phosphoric acid and distill water. Then 
2g of sulphanylamide was also dissolved in the solution to 
form the Griess reagent and stored in a dark cupboard prior to 
use. Sodium nitrite stock solution of 0.1mg of nitrite reagent 
in 10ml of distilled water was freshly prepared.  It was diluted 
in 10 folds and further into  5 serial dilution of 0 µl, 250 µl, 
500 µl, 750 µl and 1000 µl, then made up to 1ml. Clean test 
tubes were arranged in duplicate and labeled accordingly, then 
measured 200µl of the samples and different standard dilution  
into the corresponding  test tubes. Also, 1800µl of the Griess 
reagent was added in all the test tubes and incubated at room 
temperature for 10min. The absorbance at 540nm was read, 
while the concentration calculated using standard curve 
expressed in mg/ml. 
 
Lipid peroxidation assay: Lipid peroxidation assay was 
carried out according to the modified method of Iqbal et al., 
(1996).  The reaction mixture contains 0.1M, pH 7.4 
phosphate buffer, 100mM ferric chloride, 10% trichloroacetic 
acid and 0.67% thiobarbituric acid (TBARS). The assay was 
carried outin duplicate using 200µl of homogenates mixed 
with 0.58ml phosphate buffer, 200µlascorbic acid and 20µl 
ferric chloride against the blank which contain distill water in 
place of homogenate. The mixture was placed in a mechanical 
water bath for 1hr at the temperature of 37oC. 1ml of TCA 
solution was added to stop the reaction process then followed 
by addition of 1ml of TBARS before placing in a boiling water 
bath for 20 min. The solution was further centrifuged at 
3000rpm for 10min after cooling in a crushed ice bath for 
about 3 to 4 min. The supernatant was obtained and the 
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absorbance measured at 535nm using spectrophotometer 
against the reagent blank solution. The result of the assay was 
expressed in nMTBARS/min/mg tissue, using molar 
extinction coefficient 1.56x105M-1cm-1. The value of MDA 
obtained can be calculated using the expression below:  
 
MDA(µM) = Asample / L X £ X DF 
Asample = Absorbance of the sample 
L = light path = 1cm 
£= molar absorptivity = 1.56 x 105 M-1 cm-1 
DF = dilution factor = 1 
 
Reduced glutathione assay: The level of reduced glutathione 
in the liver was estimated using the method of Moron et al. 
(1979) with slight modification. DTNB reagent solution was 
freshly prepared by dissolving 0.6mM concentration of DTNB 
in 0.2M, pH 8.0 phosphate buffer, while 5% of trichloroacetic 
acid (TCA) was prepared in distilled water. The standard stock 
concentration of reduced glutathione (GSH) was prepared by 
dissolving 0.1mg of GSH in 1ml of distilled water. The assay 
was carried out in duplicate using 4ml of TCA solution in test 
tubes containing 1ml of the homogenates. The solutions were 
centrifuged at 4000rpm for 10min using a table top centrifuge. 
The supernatant (0.2ml) and the standards were pipetted in 
duplicate and added with 0.9ml phosphate buffer prepared, 
then, 2ml of DTNB solution was also added to all the test 
tubes. The absorbance was measured against the blank which 
contains distilled water instead of samples and the 
concentrations of GSH in the samples were extrapolated from 
the standard curve, expressed in µg/GSH/g sample. 
 
Glutathione peroxidase (GPx) assay: The analysis of GPx 
activity was carried out using a modified method of Rotruck 
et al. (1973). Different chemicals for the analysis were 
prepared in solution of 0.2M, pH 8.0 phosphate buffer, 10mM 
Sodium azide, 4mM reduced Glutathione (GSH), 2.5mM 
H2O2, 10% Tricarboxylic acid (TCA), 0.3M Disodium 
hydrogen phosphate, 0.6mM DTNB in phosphate buffer and 
distilled water. The analysis was carried out in duplicate by 
mixing 0.1ml of the liver homogenate with 0.5ml phosphate 
buffer, 0.1ml Sodium azide, 0.2ml GSH, 0.1ml H2O2 and 1ml 
distilled water. The mixture was incubated at 37oC for 3min, 
then, added with 0.5ml TCA and centrifuged at 3000rpm for 
10min. 0.1ml of the supernatant collected was mixed with 
0.9ml Disodium hydrogen phosphate and 1ml of DTNB, then, 
the absorbance was taken at 412nm against the blank solution 
containing every other components except the homogenate. 
The activity of the GPx is calculated using the expression: 
 
GPx activity (µmol/mg sample) = O.D412 X TV X df / 6.22 X 103 X EV 
     
Where;  
O.D412 = Absorbance at 412nm, TV = Total volume, df = dilution 
factor, EV= Enzyme volume, 6.22 X103 = Extinction coefficient. 
 
Superoxide dismutase (SOD) assay: The modified method 
of McCord and Fridovich (1969) was used to assay for the 
activity of superoxide dismutase. The reaction mixture 
contained 75mM, pH 8.0 Tris-buffer, 30mM EDTA and 2mM 
pyrogallol. 100µl of the liver homogenate was pipette into 
clean test tubes in duplicate, 2.5ml Tris-buffer was added 
followed by addition of 100µl of EDTA. The enzyme reaction 
was initiated by addition of 300µl of pyrogallol. The increased 
in absorbance is read at an interval of 30secs for 150secs 
against the blank containing 100µl of distilled water in place 
of homogenate. The maximum absorbance is read at 
wavelength of 420nm. 
 The differences in absorbance per minute were calculated 
using the expression of;                  
Change in Absorbance per minute (∆Abs./min) = B6 – B2/2.  
Where, B6 = Absorbance at 150secs and B2 = Absorbance at 30secs. 
 
The percentage activity of the enzyme is obtained as: 
   
% Activity = 100 – 100 X Increased in absorbance of substrate) 
   Increased in absorbance of blank 
 
The activity of SOD was given in percentage (%) 
 
Statistical Analysis 
All the experiments were done in duplicates. The data were 
expressed as means ± SEM; n=6 per treatment. Statistical 
analysis was done using student t-test with Duncan post-hoc 
test  (SPSS version 17). Significant differences were 





The presence of tannins, cardiac glycosides, alkaloids and 
steroids in Taraxacum officinale leaf extract were observed as 
shown in Table 1.  
 
Table 1:  
Phytochemical composition of Taraxacum officinale leaf extract.  
Phytochemical constituents  Taraxacum officinale extract 
Cardiac glycosides       + 
Tannins       + 
Alkaloids       + 
Saponins       - 
Steroids       + 
The positive sign (+) showed present and negative sign (-) showed absent 
 
Total phenolic and flavonoid contents: Phenolic content in 
100 mg/ml and 200 mg/ml extracts were 2.175 ± 0.032 µg/ml 
TAE and 3.097 ± 0.391 µg/ml TAE respectively while total 
flavonoid content in 100 mg/ml and 200 mg/ml extracts were 
0.173 ± 0.001 µg/ml RE and 0.197 ± 0.002 µg/ml RE 
respectively (Table 2). 
  
Table 2:  
Total phenolic and flavonoid contents of 100mg/ml and 
200mg/ml leaf extract of Taraxacum officinale  
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Ferric Reducing Antioxidant Power (FRAP) value in the 
liver: Administration of 100mg/kgbw and 200mg/kgbw plant 
extract in the diabetic rats resulted in insignificant decrease in 
FRAP value of the liver compared to the diabetic control while 
non-diabetic rats showed decrease FRAP value at 




Figure 1:  
Effect of Taraxacum officinale leaf extract on Ferric Reducing  
Antioxidant Power (FRAP) in the liver of diabetic rats (p < 0.05). 
 
Figure 2:  
Effect of Taraxacum officinale leaf extract on nitrite concentration in 
the liver of diabetic rats (p < 0.05). 
** indicates significant difference in comparison to non-diabetic (ND) 
control 
## indicates significant difference in comparison to diabetic (STZ) control 
 
Figure 3:  
Effect of Taraxacum officinale leaf extract on lipid peroxidation in 
the liver of diabetic rats (p < 0.05).  
** indicates significant difference in comparison to non-diabetic (ND) 
control 
## indicates significant difference in comparison to diabetic (STZ) control 
 
Level of nitrite in the liver: Nitrite level in the liver was 
significantly decreased in both diabetic and non-diabetic rats 
compared to their respective controls upon administration of 
the plant extracts as shown (Figure 2). 
Level of lipid peroxidation in the liver: The diabetic control 
group showed no significant difference in the level of lipid 
peroxidation product compared to the non-diabetic control 
group as shown in Figure 3. In the non-diabetic rats, 
administration of 100mg/kgbw plant extract caused lipid 
peroxidation product to decrease significantly (p < 0.05) as 
compared to the non-diabetic control. In the diabetic rats, 
administration of 100 mg/kgbw and 200 mg/kgbw, lipid 
peroxidation product decreased significantly (p < 0.05) as 
compared to the diabetic control.  
 
Concentration of reduced glutathione (GSH) in the liver: 
The GSH concentration in the liver is shown in Figure 4. In 
non-diabetic rats, administration of both 100 mg/kgbw and 
200 mg/kgbw plant extract significantly decreased GSH 
concetration compared to the non-diabetic control. In the 
diabetic rats, administration of both 100 mg/kgbw and 
200mg/kgbw extracts caused GSH concentration to increase 
significantly (p < 0.05) as compared to the diabetic control. 
 
Activity of glutathione peroxidase (GPx) in the liver: The 
activity of GPx in the diabetic control rats was insignificantly 
increased as compared to the non-diabetic control. In the non-
diabetic rats, administration of both 100 mg/kgbw and 200 
mg/kgbw extracts caused GPx activity to increase 
significantly (p < 0.05) as compared to the non-diabetic 
control, while GPx activity decreased significantly in diabetic 
rats administered with both 100 mg/kgbw and 200 mg/kgbw 




Figure 4:  
Effect of Taraxacum officinale leaf extract on reduced glutathione 
concentration in the liver of diabetic rats (p < 0.05).  
** indicates significant difference in comparison to non-diabetic (ND) control 
## indicates significant difference in comparison to diabetic (STZ) control 
 
 
Figure 5:  
Effect of Taraxacum officinale leaf extract on the level of  
glutathione peroxidase in the liver of diabetic rats (p < 0.05).  
** indicates significant difference in comparison to non-diabetic (ND) control 
## indicates significant difference in comparison to diabetic (STZ) control 
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Activity of Superoxide dismutase (SOD) in the liver: The 
percentage SOD activity in diabetic control rats showed no 
significant increase as compared to the non-diabetic control. 
Administration of 200 mg/kgbw extract caused SOD to 
increase significantly (p < 0.05) in non-diabetic rats as 
compared to the non-diabetic control. In the diabetic rats, 100 
mg/kgbw and 200 mg/kgbw extract increased SOD activity 




Figure 6:  
Effect of Taraxacum officinale leaf extract on percentage SOD 
activity in the liver of diabetic rats (p < 0.05).  
** indicates significant difference in comparison to non-diabetic (ND) control 
## indicates significant difference in comparison to diabetic (STZ) control 
DISCUSSION 
 
Taraxacum officinale leaf extract possesses phenols, 
flavonoids, tannins, cardiac glycosides, alkaloids and steroids 
that have the ability to reduce oxidative stress (Rajurkar and 
Hande, 2011). Ferric-Reducing Antioxidant Power (FRAP) 
evaluates the antioxidant potential of non-enzymatic defenses 
in biological fluid, where it provides a measure of antioxidant 
ability (Benzie and Strain, 1996). The mechanism of FRAP is 
based on electron transfer which is the ability to reduce Fe3+ 
to Fe2+ at suitable pH.  This occurs in the presence of 2,4,6-
trypyridyl-s-triazine (TPTZ) with formation of Fe2+ complex, 
followed by a colour change. The effect of Taraxacum 
officinale leaf extract on the liver of diabetic rats showed 
insignificant difference in FRAP value as compared to non-
diabetic control group. This suggests that, diabetic rats 
respond to produce more antioxidants to curtail the oxidative 
species produced in the disease state. Treatment with 100 
mg/kgbw extract showed marked reduction in the FRAP value 
in non-diabetic rats while 200mg/kgbw extract showed no 
difference in FRAP value when compared with the normal 
control. Lans et al. (2007) in their findings, discovered that the 
leaves of Taraxacum officinale pre-ingested by ruminants 
during pregnancy strengthened the liver by maintaining the 
FRAP level in preeclampsia induced animals. Our study 
indicated that in diabetic condition, the administration of 
100mg/kgbw and 200mg/kgbw extracts showed no significant 
effect in FRAP value. 
 Nitrite in the body is reduced to nitric oxide, an unstable 
molecule, which can combine with oxygen to form a 
dangerous nitrogen radical known as peroxinitrite. Excess 
nitrite can also react with circulating proteins in the internal or 
external cellular matrix to form a modified protein structure of 
nitrosamine which can attack and cause dysfunction to cellular 
structure (Miles et al., 1996). The nitrite level was found to be 
non-significantly different in both diabetic and non-diabetic 
controls, but a significant decrease in nitrite level was 
observed in the liver of diabetic and non-diabetic rats treated 
with the plant extract when compared with the control groups. 
In this study, the extracts showed marked reduction of nitrite 
in the liver of both diabetic and non-diabetic treated rats. Colle 
et al. (2012) reported that the leaf extract of Taraxacum 
officinale decreased nitrite concentration. In the findings of 
Hu and Kitts (2005), it was reported that the activity of 
Taraxacum officinale flower extracts against RNS was 
attributed to the phenolic content. Ethanolic extract of 
Taraxacum officinale flowers has also been demonstrated to 
have suppressive effects on NO• production in macrophage 
cells (Jeon et al., 2008). Administration of 100mg/kgbw and 
200mg/kgbw extract showed significant decrease in nitrite 
level in both non-diabetic and diabetic rats.  
 Lipid peroxidation is a function of interaction of 
polyunsaturated lipids with oxidative species (Ayala et al, 
2014).  This process involves the interaction of free radicals 
with the membrane lipids by taking electron from the lipids, 
resulting in damage to the cell membrane. Lipid peroxidation 
indicates the level of oxidative stress as it forms reactive 
aldehydes such as malondialdehyde (MDA) and 4-
hydroxynonenal (4-HNE). (Ayala et al, 2014).  The product of 
this reaction, i.e, MDA in the liver was found to be 
insignificantly different in both diabetic and non-diabetic 
control groups. Administration of 100mg/kgbw to non-
diabetic rats significantly decrease lipid peroxidation product 
when compared to the non-diabetic control. In the diabetic 
condition, both 100 mg/kgbw and 200 mg/kgbw showed 
marked decrease in the lipid peroxidation product in the liver 
which was in contrast to the work of Choi et al. (2010), that 
supplementation with dandelion (Taraxacum officinale) leaf 
showed no significant reduction in TBARS level of fat-
induced experimental rats. However, Hfaiedh et al. (2014) 
showed that Wistar rats pretreated with Taraxacum officinale 
had a significant decrease in the hepatic MDA content. In his 
work, MDA content was significantly increased in sodium 
dichromate-treated control group animals, while prior 
administration of Taraxacum officinale extract along with 
sodium dichromate showed a decrease in liver MDA content 
when compared with sodium dichromate-treated control rats.  
 GSH assay involved an optimized enzymatic recycling 
method and glutathione reductase where the sulphdryl group 
of the glutathione reacts with 5, 5 – dithiobis – 2-nitrobenzonic 
acid (DTNB) to form GSTNB disulfides mixture. The level of 
reduced glutathione (GSH) was not significantly different 
found to have increased in diabetic control group compared to 
non-diabetic group. This might be considered as a result of the 
body response to diabetic condition by producing more GSH 
to mob-out the oxidative species. This effect was found to 
GSH level increased significantly by in  the administration of 
100 mg/kg bw and 200 mg/kg bw extracts to diabetic group. 
due to body adjustment to balance the unhealthy situation. 
Non-diabetic groups treated with the plant extract showed no 
significant different in GSH compared with the normal 
control. The work of Choi et al. (2010) and El-gengaihi et al. 
(2016) have indicated that GSH level in the liver of 
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Taraxacum officinale treated rats increased significantly due 
to excess oxidative species production. Hence, it can be 
deduced that Taraxacum officinale leaf extract could increase 
GSH level in diabetic conditions.  
 Superoxide dismutase (SOD) is an antioxidant enzyme that 
catalyzes the reduction of superoxide (O2−) radical into 
molecular oxygen (O2) or hydrogen peroxide (H2O2). In this 
study, the activities of SOD were insignificantly increased in 
diabetic control as compared to non-diabetic control while 
diabetic rats treated with 100 mg/kgbw and 200 mg/kgbw 
extracts showed significant increase in % SOD activity as 
compared to diabetic control.  Glutathione peroxidase (GPx) 
is responsible for catalyzing the reduction of hydrogen 
peroxide to water and oxygen. The GPx activity in the liver 
increased in diabetic control as compared with non-diabetic 
control in this study. The increase in GPx activity in diabetic 
control might be as a result of disease condition causing the 
body to synthesize more of the antioxidant enzymes to curtail 
oxidative species. Administration of 100 mg/kgbw and 
200mg/kgbw extract in non-diabetic groups increased GPx 
activity significantly as compared to the normal control, 
indicating the potential of the plant extract to enhance the 
antioxidant system of the body in a healthy individual. 
Diabetic groups treated with the 100mg/kgbw and 
200mg/kgbw plant extract showed decrease in GPx activity. 
 In conclusion, this study revealed that aqueous leaf extract 
of Taraxacum officinale can help to boost the antioxidant 
capacity in the liver in diabetic condition. Isolation of 
bioactive compounds in the plant is recommended to have 
better insights into the specific phytochemicals that exert 
health promoting potentials.  
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